Gene: PSKH1
Official Full Name: protein serine kinase H1provided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in signal transduction. Predicted to act upstream of or within determination of left/right symmetry; heart development; and protein phosphorylation. Located in cytosol and nuclear speck. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35855 | PSKH1 Knockout cell line (HeLa) | Human | PSKH1 | 1:3~1:6 | Negative | Online Inquiry |
KO35856 | PSKH1 Knockout cell line (HCT 116) | Human | PSKH1 | 1:2~1:4 | Negative | Online Inquiry |
KO35857 | PSKH1 Knockout cell line (HEK293) | Human | PSKH1 | 1:3~1:6 | Negative | Online Inquiry |
KO35858 | PSKH1 Knockout cell line (A549) | Human | PSKH1 | 1:3~1:4 | Negative | Online Inquiry |
PSKH1 Gene Knockout Cell Lines represent a cutting-edge tool for molecular biology research, specifically designed to facilitate the investigation of the PSKH1 gene's functions and related signaling pathways. These cell lines have been created through precise gene editing techniques, allowing for the specific disruption of the PSKH1 gene, which is known to play a crucial role in various cellular processes, including cell cycle regulation, apoptosis, and signal transduction.
The primary mechanism through which PSKH1 Gene Knockout Cell Lines operate is through the elimination of PSKH1 protein expression. This disruption enables researchers to assess the functional consequences on cellular behavior, such as changes in growth patterns, response to external stimuli, and involvement in disease mechanisms. As such, these cell lines serve as invaluable models for examining the PSKH1 gene's role in both normal physiology and pathological conditions, including cancer and other proliferative diseases.
From a scientific standpoint, the applicability of PSKH1 Gene Knockout Cell Lines extends to research settings focused on gene function analysis, therapeutic target validation, and drug discovery processes. The ability to dissect gene function in a controlled in vitro environment allows for a better understanding of complex biological pathways, facilitating the development of innovative therapeutic strategies.
Compared to traditional cell lines or other knockout models, PSKH1 Gene Knockout Cell Lines offer the unique advantage of specificity and efficiency. The targeted nature of gene knockout technology enables streamlined experiments with reproducible results, reducing confounding variables associated with nonspecific gene disruption methods. Additionally, these lines have been rigorously characterized and validated, ensuring high-quality performance that meets the standards of advanced research.
For researchers and clinicians, incorporating PSKH1 Gene Knockout Cell Lines into their work opens up new avenues for the exploration of gene function and disease mechanisms. This product not only enhances experimental design but also drives innovative discoveries that could lead to significant advancements in medical science.
Our company stands at the forefront of biological product development, with a strong commitment to providing high-quality tools for the scientific community. We leverage our expertise in genetic engineering to offer premium products like PSKH1 Gene Knockout Cell Lines, designed to empower researchers in their quest for knowledge and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.